Drug Res (Stuttg) 2013; 63(08): 420-423
DOI: 10.1055/s-0033-1345109
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Platinum(IV) Complexes with Some Derivatives of 5-Methyl-5-(4-pyridyl)Hydantoin. Synthesis, Study and Comparative Pharmacological Investigation

A. Bakalova
1   Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
,
R. Buyukliev
1   Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
,
Z. Ivanova
1   Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
,
G. Momekov
2   Department of Pharmacology, Faculty of Pharmacy, Pharmacotherapy and Toxicology, Sofia, Medical University of Sofia, Bulgaria
,
D. Ivanov
1   Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 21. Februar 2013

accepted 29. März 2013

Publikationsdatum:
15. Mai 2013 (online)

Preview

Abstract

3 Pt(IV) complexes with 3-ethyl-5-methyl-5-(4-pyridyl)hydantoin (4), 3-propyl-5-methyl-5-(4-pyridyl)hydantoin (5) and 3-benzyl-5-methyl-5-(4-pyridyl)hydantoin (6) with general formulae cis-[Pt(L)2Cl4] were synthesized. The novel compounds were characterized by elemental analysis, IR, 1H, 13C, NMR spectra in solid state and in solution. The studies showed that the ligands coordinate to the platinum ions in a monodentate manner through the nitrogen atom from the pyridine ring. The cytotoxic activity in vitro of newly synthesized complexes as well as their previously prepared analogous of Pt(IV) with other derivatives like 3-amino-5-methyl-5-(4-pyridyl)hydantoin (1), 5-methyl-5-(4-pyridyl)hydantoin (2), 3,5-dimethyl-5-(4-pyridyl)hydantoin (3) was screened against a panel of human tumor cell lines. The tested compounds displayed cytotoxic activity which was invariably superior with the Pt(IV) complex with 3-benzyl-5-methyl-5-(4-pyridyl)hydantoin (6) causing 50% inhibition of cellular viability at micromolar concentration, though the activity of the other studied Pt(IV) complexes proved to greatly decrease in the order 5-4-3-2-1.